Overview
Melanotan I, also known by its scientific name afamelanotide, is a synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH), a naturally occurring peptide produced in the pituitary gland that plays a role in regulating skin pigmentation. It was developed by modifying the natural alpha-MSH sequence to improve its stability and potency, resulting in the compound identified by CAS number 75921-69-6 with a molecular weight of approximately 1646.8 Da. As a melanocortin receptor agonist, it is categorized among peptides that interact with the melanocortin system, which researchers have linked to pigmentation biology and other physiological processes. Published research has explored Melanotan I in contexts ranging from the study of skin pigmentation mechanisms to its potential roles in peripheral nerve regeneration when incorporated into specialized delivery systems. This peptide is intended strictly for laboratory and preclinical research purposes only and is not approved or intended for human use or consumption.
Research & Bioactivity
Melanotan I is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH) that researchers have studied primarily in relation to melanocortin receptor signaling, particularly its interactions with the melanocortin 1 receptor (MC1R), which plays a central role in regulating skin pigmentation through melanin synthesis. Studies have examined its pharmacological profile as a melanocortin receptor agonist, and it has been investigated as a tool compound in research aimed at better characterizing the melanocortin receptor family, a group of G protein-coupled receptors with broad physiological relevance including roles in pigmentation, energy homeostasis, and steroidogenesis. Research has also explored Melanotan I in the context of tanning biology, where systematic reviews have assessed its mechanisms of action alongside other agents that influence melanin production pathways. Beyond pigmentation, preclinical research has investigated the potential utility of melanocortin peptides, including analogues such as Melanotan I, in peripheral nerve regeneration models, with studies incorporating NDP-MSH — a closely related compound — into biodegradable nerve conduit systems evaluated in laboratory settings. The broader scientific literature continues to examine the role of melanocortin signaling in skin endocrinology, with Melanotan I serving as a research reference compound for understanding how hormonal pathways regulate pigmentary responses at the cellular level.
Published Research
Insights into Tanning Biology and Tanning Products.
Resnick G, Khajeh-Afzaly M, Yousefian F, Raza A, Issa NT — 2026
OBJECTIVE: This systematic review aims to critically assess the literature on the mechanisms of action, clinical uses, formulation strategies, and adverse effects of self-tanning agents, with a focus on dihydroxyacetone (DHA), melanotan, forskolin, and carotenoids. METHODS: A systematic literature review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Studies were screened for relevance to the mechanisms of action, clinical applications, chemical formulations, or adverse effects of self-tanning molecules. A total of 68 peer-reviewed studies were included. RESULTS: DHA induces pigmentation via the Maillard reaction and has demonstrated additional dermatologic applications, including use in vitiligo and erythropoietic protoporphyria and as a potential topical antifungal. Concerns persist about DHA-related cytotoxicity, genotoxicity, and systemic absorption. Unregulated melanotan I and II use has caused serious adverse effects, including rhabdomyolysis, renal infarction, and priapism. While forskolin stimulates melanin production independently of melanocortin receptors and has demonstrated efficacy in animal models, carotenoids, when ingested orally, accumulate in skin and subcutaneous fat, creating a yellow-orange hue. Both agents remain underresearched in human populations. LIMITATIONS: Limitations include lack of standardized reporting across included studies, variability in study outcomes, and limited long-term safety data. CONCLUSION: Sunless tanning agents offer UV-free alternatives for cosmetic pigmentation but are not without risk. While DHA and melanotan remain the dominant agents in current use, forskolin and carotenoids offer alternative pathways for pigmentation and photoprotection. Further clinical studies are necessary to evaluate long-term safety, efficacy across skin types, and formulation optimization. Regulatory frameworks and dermatologic guidance must evolve to reflect the expanding landscape of sunless tanning modalities.
Biodegradable polyurethane nerve conduits functionalized with NDP-MSH-loaded self-assembling peptide hydrogels for peripheral nerve regeneration.
Li J, Wang J, Long X, Lin J, Su M, et al. — 2026
Autologous nerve grafting remains the clinical gold standard for segmental peripheral nerve repair, but it is limited by donor-site morbidity and graft availability. Nerve guidance conduits (NGCs) offer a promising alternative for peripheral nerve repair. In this work, we engineered a fully biodegradable waterborne polyurethane (BWPU) NGC functionalized with a pH-responsive self-assembling peptide (SAP) loaded with [Nle4, D-Phe7]-α-melanocyte-stimulating hormone (NDP-MSH)-an α-MSH analogue that activates melanocortin receptors and has been reported to attenuate oxidative stress, apoptosis, and neuroinflammation. BWPU (17 mol% PEG) was fabricated into porous conduits and integrated with NDP-MSH-loaded SAP to provide mechanical support for peripheral nerve repair while enabling controlled peptide release, thereby coupling structural support with antioxidant/pro-survival signaling. , NDP-MSH at appropriate concentrations attenuated oxidative damage in RSC96 Schwann cells by reducing intracellular reactive oxygen species (ROS) and LDH release. , 10-mm rat sciatic nerve defects were bridged with BWPU, SAP@BWPU, NDP-MSH@SAP@BWPU conduits, or Autograft. Early post-implantation, NDP-MSH@SAP@BWPU reduced apoptosis and promoted an M2-enriched immune microenvironment. At 60 days post-repair, the NDP-MSH@SAP@BWPU group achieved structural, functional, and electrophysiological outcomes comparable to the Autograft group. These findings demonstrate that NDP-MSH delivery a BWPU-SAP depot-enabled conduit is an effective strategy to biofunctionalize biodegradable NGCs and may offer a viable alternative to autografts for peripheral nerve repair.
[Hormones and skin pigmentation: fundamentals and clinical relevance].
Böhm M — 2026
Skin pigmentation by the endogenous pigment melanin is a highly coordinated process in which hormones play a crucial role. They are synthesized not only in classical endocrine organs but also in the skin itself, which acts as an independent endocrine organ. Among the endocrine target structures of the skin, the melanocortin 1 receptor (MC1R) is of particular importance. Via its high expression and tonic activity in melanocytes, as well as by binding to natural melanocortins such as α‑melanocyte-stimulating hormone (α-MSH), being generated in the skin following ultraviolet (UV) light irradiation, MC1R crucially contributes to the different skin phototypes. Gene mutations of MC1R resulting in defective cyclic adenosine monophosphate (cAMP)-mediated signalling can lead to a shift of the eumelanin/pheomelanin ratio towards the pro-oxidant, yellowish-orange pheomelanin. In patients with Addison's disease and associated syndromes, ectopic proopiomelanocortin syndrome and primary adrenal cortex insufficiency elevated melanocortin levels result in increased melanin content of the skin. Two synthetic melanocortins, afamelanotide (NDP-α-MSH) and setmelanotide, are currently approved in Germany. By targeting MC1R directly (afamelanotide) or as a bystander effect (setmelanotide), both agents increase the skin melanin content. Non-licenced synthetic melanocortins, on the other hand, are used as lifestyle products in an unregulated manner. Additional hormones regulating melanogenesis and skin pigmentation include estrogens, thyroid hormones, insulin, insulin-like growth-factor‑1 and melatonin. They are of physiological and clinical relevance during pregnancy and in patients with melasma and vitiligo. Autoimmune thyroid disorders and diabetes are associated with non-segmental vitiligo. Melatonin appears to have a lightening effect on skin pigmentation by melanin.
A single-centre, prospective, qualitative analysis of knowledge, attitudes and behaviour of sunbed use among patients attending a pigmented lesion clinic in a tertiary referral centre.
Lai FY, Quigley C, Murray G, Gordon A, Yong JF, et al. — 2025
BACKGROUND: Indoor tanning through sunbeds is linked to a heightened risk of skin cancers, particularly cutaneous squamous cell carcinoma and basal cell carcinoma, with significant increases in risk for users aged < 35 years. Despite regulations established by the Public Health (Sunbeds) Act 2014 in Ireland, sunbed use persists, primarily for cosmetic reasons. OBJECTIVES: To analyse the characteristics, attitudes and behaviours of sunbed users attending an Irish dermatology outpatient clinic. METHODS: We undertook a prospective qualitative analysis of 104 consecutive patients attending a pigmented lesion clinic in a tertiary referral dermatology department in Ireland. This was done using a self-reported anonymous survey where respondents answered questions relating to their own demographic data, frequency of sunbed use, motivation for sunbed use and use of unregulated tan-enhancing agents (namely Melanotan I and II). RESULTS: The results showed that patient demographics were consistent with previous studies on sunbeds use, namely younger female patients living in urban areas. Many sunbed premises did not comply with safety regulations; over half lacked protective goggles, and nearly half received no health risk information. The reasons for sunbed use included improving appearance and confidence, with a significant number using tan-enhancing agents. Surprisingly, increased awareness of health risks did not correlate with reduced usage; many users continued tanning practices despite concerns about its adverse effects. Users of tan-enhancing agents also used sunbeds more frequently compared with nonusers. CONCLUSIONS: This study suggests a potential psychopathological aspect of tanning behaviours similar to addictive disorders like smoking and alcohol. Patients may benefit from psychological and behavioural interventions such as cognitive behavioural therapy to address their compulsive behaviour. Furthermore, there was a concerning lack of compliance with regulations in tanning salons, highlighting a public health issue. The rising use of unregulated tanning agents, especially among younger people, poses additional risks, including blood-borne infections. This study underscores the need for targeted educational interventions among younger age groups and stricter enforcement of regulations to mitigate health risks associated with indoor tanning. Understanding the complex motivations behind sunbed use is crucial for developing effective strategies to reduce its prevalence and promote safer alternatives.
Recommended Tool Compounds for the Melanocortin Receptor (MCR) G Protein-Coupled Receptors (GPCRs).
Weirath NA, Haskell-Luevano C — 2024
The melanocortin receptors are a centrally and peripherally expressed family of Class A GPCRs with physiological roles, including pigmentation, steroidogenesis, energy homeostasis, and others yet to be fully characterized. There are five melanocortin receptor subtypes that, apart from the melanocortin-2 receptor (MC2R), are stimulated by a shared set of endogenous agonists. Until 2020, X-ray crystallographic and cryo-electron microscopic (cryo-EM) structures of these receptors were unavailable, and the investigation of their mechanisms of action and putative ligand-receptor interactions was driven by site-directed mutagenesis studies of the receptors and targeted structure-activity relationship (SAR) studies of the endogenous and derivative synthetic ligands. Synthetic derivatives of the endogenous agonist ligand α-MSH have evolved into a suite of powerful ligands such as NDP-MSH (melanotan I), melanotan II (MTII), and SHU9119. This suite of tool compounds now enables the study of the melanocortin receptors and serves as scaffolds for FDA-approved drugs, means of validating stably expressing melanocortin receptor cell lines, core ligands in assessing cryo-EM structures of active and inactive receptor complexes, and essential references for high-throughput discovery and mechanism of action studies. Herein, we review the history and significance of a finite set of these essential tool compounds and discuss how they are being utilized to further the field's understanding of melanocortin receptor physiology and greater druggability.